期刊文献+

陈泽涛治疗肝癌经验 被引量:4

下载PDF
导出
摘要 陈泽涛认为肝癌病理因素为虚、毒、瘀等,病因病机为内有脏腑气虚血亏,外有邪毒入侵,为正虚邪实之证。临床从肝气郁结、气滞血瘀、湿热聚结、肝阴亏虚等方面辨证论治,治以疏肝健脾、行气活血、清热利胆、养血柔肝。
出处 《山东中医杂志》 2014年第12期1030-1032,共3页 Shandong Journal of Traditional Chinese Medicine
  • 相关文献

参考文献3

二级参考文献17

  • 1沈锋,吴孟超.肝癌切除术后的抗复发治疗[J].中华医学杂志,2005,85(41):2886-2888. 被引量:26
  • 2奚韬,闫振林,王葵,李俊,夏勇,沈锋,吴孟超.术后经导管动脉化疗栓塞对不同病理特征肝癌的抗复发作用[J].中华外科杂志,2007,45(9):587-590. 被引量:23
  • 3Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005,55(2) :74-108.
  • 4Spangenberg HC, Thimme R, Blum HE. Serum markers of hepatocellular carcinoma [ J]. Semin Liver Dis, 2006, 26 ( 4 ) : 385-390.
  • 5Libbrecht L, Severi T, Cassiman D, et al. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodtries [J]. Am J Surg Pathol, 2006, 30(11):1405-1411.
  • 6Zinkin NT, Grall F, Bhaskar K, et al. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease [J]. Clin Cancer Res, 2008, 14(2) :470-477.
  • 7Lee JS, Heo J, Libbrecht L, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells [J]. Nat Med, 2006, 12(4) :410-416.
  • 8Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term resuits of percutaneous image-guided radiofrequency ablation [ J ]. Radiology, 2005, 234 ( 3 ) : 961-967.
  • 9Llovet JM. Updated treatment approach to hepatocellular carcinoma [J]. J Gastroenterol, 2005, 40(3):225-235.
  • 10Huang GT, Lee PH, Tsang YM, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study [ J]. Ann Surg, 2005, 242( 1 ) :36-42.

共引文献830

同被引文献62

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部